# Miray Tayfun

> Miray Tayfun is the co-founder and CEO of Vivoo, a San Francisco-based health technology company that turns urine test strips into personalized wellness insights via a mobile app. A bioengineering graduate and serial founder, she built Vivoo from a personal frustration with expensive and slow health testing into a platform serving 300,000+ users across 50+ countries. Backed by Tim Draper and $19.4M in total funding, Vivoo expanded from subscription test strips to a $99 smart toilet unveiled at CES 2026, named Best of CES by Gadget Flow. Tayfun is a 2019 Australian Financial Review Top 100 Women of Influence honoree and 2018 Laureate Here for Good Award winner.

- **Role:** Co-Founder & CEO at Vivoo
- **Organizations:** Vivoo, Vivosens Biyoteknoloji, Young Guru Academy (YGA)
- **Nationality:** Turkish
- **Education:** High School Diploma (Science Department), Istek Ozel Kemal Ataturk Lisesi, Bachelor of Applied Science (B.A.Sc.) in Bioengineering, Yildiz Technical University, Go-to-Market Strategies; Diet and Gene Expression, Stanford University (postgraduate programs)
- **Known for:** 2018 Laureate Here for Good Award winner, 2019 Australian Financial Review Top 100 Women of Influence, Built Vivoo to 300,000+ users across 50+ countries

## Career timeline

- **2013** — Volunteer at Young Guru Academy (YGA), a Harvard Business School partner leadership program
- **2014** — Key Account Manager at Smarte
- **2014** — Manufacturing and Operations at Abdi Ibrahim Pharmaceuticals
- **2015** — Co-Founded Vivosens Biyoteknoloji (medical diagnostics startup)
- **2017** — Co-Founded Vivoo (at-home urine wellness tracker) in San Francisco
- **2018** — Vivoo launches publicly; Tayfun wins Laureate Here for Good Award
- **2019** — Named to Australian Financial Review Top 100 Women of Influence
- **2021** — Vivoo raises $6M Series A led by Tim Draper (Draper Associates); 50,000+ users in 100+ countries
- **2024** — Vivoo raises Series B; total funding reaches $19.4M
- **2025** — Vivoo launches reproductive health tests and announces smart toilet at CES 2025; 300,000+ users in 50+ countries
- **2026** — Vivoo Smart Toilet launches at $99, named Best of CES 2026 by Gadget Flow; expands to 120+ countries

## Achievements

- 2018 Laureate Here for Good Award winner
- 2019 Australian Financial Review Top 100 Women of Influence
- Built Vivoo to 300,000+ users across 50+ countries
- Raised $19.4M in total funding including Series A led by Tim Draper
- Launched Vivoo Smart Toilet named Best of CES 2026 by Gadget Flow
- Built an organically 70% female leadership team
- Vivoo operates in 120+ countries with 150+ organizational partnerships
- Serial founder with prior companies in medical diagnostics, smart homes, and co-living

## Latest updates

- **2026-01** — Vivoo Smart Toilet launches commercially at $99, named Best of CES 2026 by Gadget Flow; uses optical sensing technology for daily hydration tracking
- **2025-01** — Vivoo unveils reproductive health tests (FSH, LH, hCG) and second-gen smart toilet at CES 2025; reaches 300,000+ users in 50+ countries
- **2024-07** — Vivoo closes Series B funding round, bringing total funding to $19.4M
- **2024-01** — Vivoo unveils at-home UTI test at CES 2024

## Links

- Website: https://vivoo.io
- LinkedIn: http://www.linkedin.com/in/miray-tayfun-3226358a
- Twitter/X: https://twitter.com/vivooapp
- YouTube: https://www.youtube.com/watch?v=Lww-kncyHP4
- Instagram: https://www.instagram.com/miray.tayfun/
- Facebook: https://facebook.com/VivooApp/

---

Profile page: https://yespress.io/miray-tayfun
Published by YesPress — https://yespress.io
Last updated: 2026-05-12